India and the United States on 27 September 2017 renewed their commitment to collaborate in the healthcare sector at the second India-US Health Dialogue that was held on 26-27 September 2017 in New Delhi.
The two-day event saw several experts deliberate on issues of bilateral importance including communicable and non-communicable diseases, low-cost innovations, food and drug regulations, traditional medicine and access to medicines.
This Health Dialogue touched upon several issues- communicable and non-communicable diseases, health systems, biomedical research and low-cost innovations, science and health data, food and drug regulations, traditional medicine and access to medicines.
Highlights of the India-US Health Dialogue
• India and U.S. have a long history of health cooperation which has now started converging on the platform of the India-U.S. Health Dialogue.
• The dialogue addresses the health challenges faced by the people in both countries, such as cancer, R&D, communicable and non-communicable diseases, traditional medicines, access to medicines, food and drug regulation, antimicrobial resistance, etc.
• The dialogue engages both the countries on these health issues not only to address health challenges but also to contribute to global health objectives and outcomes.
• The main aim of this dialogue is to better address the health challenges faced by the people of the two countries.\
When: 27 September 2017
DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.